Our current study's results reveal that CYP1A2 SNPs (rs17861162) in breast cancer patients are associated with a 21.7% decrease in the frequency of the CC genotype and a 21.6% and 77.8% increase in the frequency of CG and GG genotypes, respectively. The gene discussed is CYP1A2; the disease is breast cancer.